Genmab A/S banner

Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 972 DKK -0.78% Market Closed
Market Cap: kr126.4B

Wall Street
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 2 217.17 DKK with a low forecast of 1 025.15 DKK and a high forecast of 3 066 DKK.

Lowest
Price Target
1 025.15 DKK
48% Downside
Average
Price Target
2 217.17 DKK
12% Upside
Highest
Price Target
3 066 DKK
55% Upside
Genmab A/S Competitors:
Price Targets
RCKT
Rocket Pharmaceuticals Inc
146% Upside
SUPN
Supernus Pharmaceuticals Inc
21% Upside

Revenue
Forecast

35% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
35% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 13 years the compound annual growth rate for Genmab A/S's revenue is 35%. The projected CAGR for the next 4 years is 16%.

Operating Income
Forecast

N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

The compound annual growth rate of Genmab A/S's operating income for the next 4 years is 24%.

Net Income
Forecast

N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

The compound annual growth rate of Genmab A/S's net income for the next 4 years is 15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?
Price Target
2 217.17 DKK

According to Wall Street analysts, the average 1-year price target for GMAB is 2 217.17 DKK with a low forecast of 1 025.15 DKK and a high forecast of 3 066 DKK.

What is Genmab A/S's Revenue forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Genmab A/S's revenue is 35%. The projected CAGR for the next 4 years is 16%.

What is Genmab A/S's Operating Income forecast?
Projected CAGR
24%

The compound annual growth rate of Genmab A/S's operating income for the next 4 years is 24%.

What is Genmab A/S's Net Income forecast?
Projected CAGR
15%

The compound annual growth rate of Genmab A/S's net income for the next 4 years is 15%.

Back to Top